Viewing Study NCT06033118


Ignite Creation Date: 2025-12-25 @ 4:43 AM
Ignite Modification Date: 2026-03-01 @ 5:00 PM
Study NCT ID: NCT06033118
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-09-13
First Post: 2023-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemox Combined With Anlotinib and Sintilimab in Advanced cHCC-ICC
Sponsor: Sichuan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module